Asbestos is the cause of many ailments and diseases, including the type of cancer disease called Mesothelioma. Its name comes from the Ancient Greece and it means “inextinguishable”, because of its astonishing fireproof qualities; they were aware of the damaging effects that it had upon workers as well. Asbestos has been widely used in a
The cancerous disease which affects the mesothelial cells of the outer lining which protects organs such as the heart, stomach and lungs and which is called mesothelium is known as Mesothelioma. The only cause of this disease is the unprotected and regular contact with asbestos. This disease is hard to diagnose because the symptoms only
The symptoms of mesothelioma take many years to manifest and that’s why this disease is very hard to be diagnosed and cured. Even if the early symptoms of mesothelioma become evident, they’re so non-specific and generalized that diagnose could be incorrect, even if an experienced doctor makes that analysis. Its symptoms could frequently be confused
ASBESTOS

Asbestos is the cause of many ailments and diseases, including the type of cancer disease called Mesothelioma. Its name comes from the Ancient Greece and it means … [Read More...]
MESOTHELIOMA SYMPTOMS

The symptoms of mesothelioma take many years to manifest and that’s why this disease is very hard to be diagnosed and cured. Even if the early symptoms of mesothelioma … [Read More...]
WHAT IS MESOTHELIOMA?

The cancerous disease which affects the mesothelial cells of the outer lining which protects organs such as the heart, stomach and lungs and which is called mesothelium is … [Read More...]
From the Blog
Risk assessment – Online interactive tools
January 27, 2012 By admin Leave a Comment
HSE has developed these interactive tools to help those working in low risk offices and shops, including charity shops understand what they need to do to assess and control risks in the workplace and comply with health and safety law.
Cancer Research UK launches trial of new drug to treat acute childhood leukaemia
January 27, 2012 By admin Leave a Comment
Cancer Research UK’s Drug Development Office has opened the first trial of a new type of drug to treat children aged from six months to 18 years with acute leukaemia, who are no longer responding to treatment.


